Immunogenicity and Safety of Yellow Fever Vaccine (Stamaril) When Administered Concomitantly With a Tetravalent Dengue Vaccine Candidate in Healthy Toddlers at 12-13 Months of Age in Colombia and Peru: A Randomized Trial.

López, Pio; Lanata, Claudio F; Zambrano, Betzana; Cortés, Margarita; Andrade, Teresa; Amemiya, Isabel; Terrones, Cynthia; Gil, Ana I; Verastegui, Hector; Marquez, Viviana; Crevat, Denis; Jezorwski, John; Noriega, Fernando

López, Pio; Lanata, Claudio F; Zambrano, Betzana; Cortés, Margarita; Andrade, Teresa; Amemiya, Isabel; Terrones, Cynthia; Gil, Ana I; Verastegui, Hector; Marquez, Viviana; Crevat, Denis; Jezorwski, John; Noriega, Fernando.

Affiliation

López P; From the *Centro de Estudios en Infectología Pediátrica, Cali, Colombia; Instituto de Investigación Nutricional, Lima, Perú; Clinical Development, Sanofi Pasteur, Montevideo, Uruguay; §Clinical Development, Sanofi Pasteur, Marcy l'Etoile, France; and ¶Clinical Development, Sanofi Pasteur, Swiftwater, Pennsylvania.

Pediatr Infect Dis J ; 35(10): 1140-7, 2016 10.

Article in En | MEDLINE | ID: mdl-27254034

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccination / Yellow Fever Vaccine / Dengue Vaccines Type of study: Clinical_trials Limits: Female / Humans / Infant / Male Country/Region as subject: America do sul / Colombia / Peru Language: En Journal: Pediatr Infect Dis J Journal subject: DOENCAS TRANSMISSIVEIS / PEDIATRIA Year: 2016 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google